Differential effects of PPARα, β/δ and γ agonists on cardiomyocytes insulin responsiveness and sensitiveness

被引：0
|
作者：
Montessuit, C. H. [1 ]
Papageorgiou, I. [1 ]
Lerch, R. [1 ]
机构：
[1] Univ Hosp Geneva, Div Cardiol, Geneva, Switzerland
来源：
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION | 2008年 / 38卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：52 / 53
页数：2
相关论文
共 50 条
  • [31] Effects of PPAR agonists on proliferation and differentiation in human urothelium
    Varley, Claire L.
    Southgate, Jennifer
    EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY, 2008, 60 (06) : 435 - 441
  • [32] Measuring biomarkers to assess the therapeutic effects of PPAR agonists?
    Chinetti-Gbaguidi, Giulia
    Staels, Bart
    PHARMACOGENOMICS, 2007, 8 (11) : 1567 - 1580
  • [33] Identification of dual PPARα/γ agonists and their effects on lipid metabolism
    Gao, Quanqing
    Hanh, Jacky
    Varadi, Linda
    Cairns, Rose
    Sjoestroem, Helena
    Liao, Vivian W. Y.
    Wood, Peta
    Balaban, Seher
    Ong, Jennifer Ai
    Lin, Hsuan-Yu Jennifer
    Lai, Felcia
    Hoy, Andrew J.
    Grewal, Thomas
    Groundwater, Paul W.
    Hibbs, David E.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2015, 23 (24) : 7676 - 7684
  • [34] Relationship between insulin resistance and low urinary pH in patients with gout, and effects of PPARα agonists on urine pH
    Takahashi, S.
    Inokuchi, T.
    Kobayashi, T.
    Ka, T.
    Tsutsumi, Z.
    Moriwaki, Y.
    Yamamoto, T.
    HORMONE AND METABOLIC RESEARCH, 2007, 39 (07) : 511 - 514
  • [35] Effects of novel PPAR δ, PPAR dual δ/γ and PPAR δ/γ/α (pan™)Agonists on PPAR-responsive genes in human adipocytes and macrophages
    Gregoire, FM
    Rakhmanova, V
    Zhang, F
    Zhu, Y
    Ma, JY
    Cheng, P
    Zhao, S
    Lavan, B
    Gustafson, TA
    DIABETES, 2005, 54 : A140 - A140
  • [36] Effects of PPARα and/or PPARγ agonists on glucose and lipid metabolism in the Zucker Diabetic fatty rat
    Tanabe, Jututaro
    Tamasawa, Naoki
    Matsuki, Kota
    Murakami, Hiroshi
    Matsui, Jun
    Sugimoto, Kazuhiro
    Ogawa, Yoshiji
    Suda, Toshihiro
    DIABETES, 2006, 55 : A521 - A521
  • [37] Combination therapy with PPARγ and PPARα agonists increases glucose-stimulated insulin secretion in db/db mice
    Yajima, K
    Hirose, H
    Fujita, H
    Seto, Y
    Fujita, H
    Ukeda, K
    Miyashita, K
    Kawai, T
    Yamamoto, Y
    Ogawa, T
    Yamada, T
    Saruta, T
    AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2003, 284 (05): : E966 - E971
  • [38] NEW INROADS DEFINING THE CARDIOMETABOLIC BENEFITS OF PPAR AGONISTS IN DIABETES AND INSULIN RESISTANCE
    Watts, G.
    ATHEROSCLEROSIS SUPPLEMENTS, 2009, 10 (02)
  • [39] EFFECTS OF GLUCOCORTICOIDS ON INSULIN-RECEPTOR AND INSULIN RESPONSIVENESS
    KNUTSON, VP
    JOURNAL OF CELL BIOLOGY, 1984, 99 (04): : A207 - A207
  • [40] Treatment with PPAR agonists improves insulin sensitivity and reduces inflammation in obese men
    Ryan, KE
    Powell, L
    McMahon, R
    McCance, DR
    Trimble, ER
    CLINICA CHIMICA ACTA, 2005, 355 : S18 - S18
12345